Sigma Investment Counselors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.39M Sell
9,777
-11
-0.1% -$2.56K 0.13% 88
2025
Q4
$2.03M Sell
9,788
-471
-5% -$93.1K 0.1% 95
2025
Q3
$1.9M Buy
10,259
+23
+0.2% +$3.94K 0.1% 93
2025
Q2
$1.56M Buy
10,236
+264
+3% +$40.6K 0.09% 96
2025
Q1
$1.65M Sell
9,972
-1,383
-12% -$216K 0.1% 92
2024
Q4
$1.64M Buy
11,355
+389
+4% +$60.3K 0.1% 94
2024
Q3
$1.78M Buy
10,966
+52
+0.5% +$8.29K 0.1% 87
2024
Q2
$1.6M Buy
10,914
+103
+1% +$15.3K 0.1% 89
2024
Q1
$1.71M Sell
10,811
-60
-0.6% -$9.55K 0.11% 91
2023
Q4
$1.7M Sell
10,871
-1,233
-10% -$189K 0.12% 89
2023
Q3
$1.89M Sell
12,104
-412
-3% -$68K 0.14% 81
2023
Q2
$2.07M Buy
12,516
+1,905
+18% +$307K 0.15% 82
2023
Q1
$1.64M Buy
10,611
+324
+3% +$52.3K 0.13% 88
2022
Q4
$1.82M Buy
10,287
+2,030
+25% +$351K 0.15% 79
2022
Q3
$1.35M Buy
8,257
+101
+1% +$17.1K 0.12% 90
2022
Q2
$1.45M Buy
8,156
+480
+6% +$85.5K 0.12% 87
2022
Q1
$1.36M Sell
7,676
-110
-1% -$18.7K 0.1% 89
2021
Q4
$1.33M Buy
7,786
+20
+0.3% +$3.27K 0.09% 91
2021
Q3
$1.25M Sell
7,766
-20
-0.3% -$3.41K 0.09% 92
2021
Q2
$1.28M Buy
7,786
+189
+2% +$31.3K 0.1% 90
2021
Q1
$1.25M Hold
7,597
0.1% 89
2020
Q4
$1.2M Buy
7,597
+6,180
+436% +$912K 0.1% 88
2020
Q3
$211K Sell
1,417
-5,836
-80% -$864K 0.04% 122
2020
Q2
$1.02M Buy
7,253
+200
+3% +$29.1K 0.11% 85
2020
Q1
$925K Buy
7,053
+150
+2% +$21.3K 0.12% 83
2019
Q4
$1.01M Sell
6,903
-85
-1% -$11.5K 0.11% 84
2019
Q3
$904K Sell
6,988
-1,315
-16% -$173K 0.1% 84
2019
Q2
$1.16M Sell
8,303
-403
-5% -$55.8K 0.14% 78
2019
Q1
$1.22M Buy
8,706
+220
+3% +$29.5K 0.15% 77
2018
Q4
$1.09M Buy
8,486
+284
+3% +$39.6K 0.15% 77
2018
Q3
$1.13M Buy
8,202
+528
+7% +$70.2K 0.14% 74
2018
Q2
$931K Sell
7,674
-856
-10% -$107K 0.12% 75
2018
Q1
$1.09M Buy
8,530
+695
+9% +$93.9K 0.15% 70
2017
Q4
$1.09M Sell
7,835
-6,982
-47% -$973K 0.15% 72
2017
Q3
$1.93M Sell
14,817
-1,344
-8% -$178K 0.27% 61
2017
Q2
$2.14M Buy
16,161
+1,089
+7% +$139K 0.33% 57
2017
Q1
$1.88M Buy
15,072
+7,091
+89% +$847K 0.3% 63
2016
Q4
$919K Sell
7,981
-248
-3% -$28.6K 0.15% 74
2016
Q3
$972K Buy
8,229
+559
+7% +$67.8K 0.16% 76
2016
Q2
$930K Buy
7,670
+132
+2% +$15K 0.16% 77
2016
Q1
$816K Sell
7,538
-68
-0.9% -$7.04K 0.14% 77
2015
Q4
$781K Sell
7,606
-125
-2% -$12.6K 0.14% 77
2015
Q3
$722K Sell
7,731
-547
-7% -$52.9K 0.14% 74
2015
Q2
$807K Buy
8,278
+1,925
+30% +$193K 0.15% 73
2015
Q1
$639K Sell
6,353
-300
-5% -$30.5K 0.12% 77
2014
Q4
$696K Hold
6,653
0.13% 78
2014
Q3
$709K Hold
6,653
0.14% 76
2014
Q2
$696K Hold
6,653
0.14% 73
2014
Q1
$654K Sell
6,653
-467
-7% -$43.3K 0.13% 71
2013
Q4
$652K Sell
7,120
-1,000
-12% -$92.2K 0.14% 72
2013
Q3
$704K Hold
8,120
0.16% 73
2013
Q2
$697K Buy
+8,120
New +$689K 0.18% 72

Other funds holding JNJ

Sigma Investment Counselors's JNJ Position: Q1 2026 in Review

Sigma Investment Counselors reduced its Johnson & Johnson (JNJ) stake by 0.11% in Q1 2026, selling an estimated $2.56K and leaving 9,777 shares worth $2.39M. The position accounts for 0.13% of the portfolio, ranked #88.

Sigma Investment Counselors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sigma Investment Counselors held 9,777 shares of Johnson & Johnson worth $2.39M as of Q1 2026.
  • Sigma Investment Counselors sold 11 Johnson & Johnson shares in Q1 2026, an estimated $2.56K.
  • Johnson & Johnson made up 0.13% of Sigma Investment Counselors's portfolio in Q1 2026, its #88 holding.
  • Sigma Investment Counselors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sigma Investment Counselors's 13F filing for Q1 2026, filed 29 Apr 2026.